CORRECTION: Raymond James Upgrades Disc Medicine to Strong Buy, Raises Price Target to $75 - Earlier Published on 9th June
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Danielle Brill has upgraded Disc Medicine (NASDAQ:IRON) from Outperform to Strong Buy and raised the price target from $50 to $75.
June 12, 2023 | 3:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Disc Medicine (NASDAQ:IRON) has been upgraded to Strong Buy by Raymond James, with a raised price target of $75.
The upgrade to Strong Buy and the raised price target by Raymond James analyst Danielle Brill indicate a positive outlook for Disc Medicine. This news is likely to increase investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100